Nav: Home

Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others

August 12, 2019

Previous studies have shown that some women who use aspirin and are later diagnosed with breast cancer may live longer, which may be related to the drug's anti-inflammatory effects on the body. However, a portion of aspirin users with breast cancer appeared to have a higher risk of mortality following breast cancer. According to a new study from researchers at the University of North Carolina at Chapel Hill Gillings School of Global Public Health, the reason for this reverse effect could be explained by DNA methylation of genes in breast cancer tumors or peripheral blood.

Methylation is a chemical modification wherein a methyl group acts like light switches along the DNA molecule, turning some genetic activity on and some off. Chemical shifts in areas of DNA that are responsible for cell death, damage and repair - such as occurs in methylation - are known contributors to the development of cancer over time. Identifying the areas where these epigenetic changes take place show promise in predicting certain risks or effective methods of treatment.

The study, published on Aug. 12 in the American Cancer Society's interdisciplinary journal CANCER, is the first to examine the effect of DNA methylation in breast tumor tissues and cells circulating in the patients' peripheral blood on the association between aspirin use and mortality in women with breast cancer.

"Chronic inflammation is a key player in the development of multiple cancer types, including breast cancer," said first author Tengteng Wang, who led this study while she was a doctoral candidate in the epidemiology department at the Gillings School. "Aspirin is a major non-steroidal anti-inflammatory drug which has anti-inflammatory properties. Given this, substantial evidence from laboratory and population studies suggests that taking aspirin may reduce the risk of developing breast cancer."

However, the association of aspirin use with death outcomes following breast cancer diagnosis remains inconclusive and inconsistent across studies, which prompted the researchers to explore whether aspirin's varying influences on breast cancer patients could be related to distinctly different DNA profiles due to methylation.

The team analyzed data from 1,266 women with breast cancer in the Long Island Breast Cancer Study who were followed for subsequent mortality. All-cause mortality after breast cancer was elevated by 67% among those who had used aspirin at least once a week for six weeks pre-diagnosis and had a methylated tumor promotor of breast cancer gene 1, known as BRCA1. Breast cancer-specific mortality decreased by 22-40% in aspirin users with unmethylated tumor promoter of BRCA1 and progesterone receptor (PR) genes, and also those with long interspersed elements-1 global hypermethylation. These results suggest real differences in breast cancer mortality risk in patient groups with these different methylation profiles in tumor tissue DNA and peripheral blood DNA.

The research team points to the need for further exploration of the potential impact - good or bad - aspirin may have on specific breast cancer patients due to their DNA methylation profiles. The findings do not indicate that anyone with elevated breast cancer risk should start taking aspirin, and people should speak to their doctors before they make changes to their medications.

"Future research designed to replicate our findings should include a larger sample size to allow examination of patterns of aspirin use, and an enlarged panel of genes to explore the role of genetic predisposition in driving overall genetic instability on survival after breast cancer diagnosis," said Wang and her mentor Marilie Gammon, a professor of epidemiology at the Gillings School and senior author on the study.
-end-
This study was funded in part by grants from the National Institutes of Health and in collaboration with researchers at Emory University, University of California at Berkeley, University of Montana, Columbia University and Icahn School of Medicine at Mount Sinai, as well as Roche Product Development in Asia-Pacific in Shanghai, China, and the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina.

Tengteng Wang is currently a postdoctoral researcher at Harvard University and Brigham and Women's Hospital.

About the University of North Carolina at Chapel Hill

The University of North Carolina at Chapel Hill, the nation's first public university, is a global higher education leader known for innovative teaching, research and public service. A member of the prestigious Association of American Universities, Carolina regularly ranks as the best value for academic quality in U.S. public higher education. Now in its third century, the University offers 74 bachelor's, 104 master's, 65 doctorate and seven professional degree programs through 14 schools including the College of Arts & Sciences. Every day, faculty, staff and students shape their teaching, research and public service to meet North Carolina's most pressing needs in every region and all 100 counties. Carolina's nearly 336,000 alumni live in all 50 states, the District of Columbia, U.S. Territories and 164 countries. More than 178,000 live in North Carolina.

University of North Carolina at Chapel Hill

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.